MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRASCORE FOCUSED FORCE PTA BALLOON

Model Number	US3513068
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Occlusion (1984); Vascular Dissection (3160)
Date of Event	10/17/2018
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
No medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.Medical records were received and the review and investigation of the reported event is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
Event or Problem Description
It was reported through the results of a clinical trial that during an angioplasty procedure with a focused force percutaneous transluminal angioplasty (pta) balloon dilatation catheter, vessel dissection was identified after three inflations in the left superficial femoral artery.Reportedly, the dissection was treated with a drug eluting stent.The event was considered to be resolved.The subject was discharged one day after the index procedure.
Additional Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned, but medical records were provided.Based on the medical records, dissection following the use of a balloon can be confirmed, but determined to be unrelated to the device.Therefore the investigation is inconclusive, as the provided evidence does not confirm an alleged deficiency with the device.Based upon the available information, the definitive root cause is unknown.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.(expiry date: 02/2020), (manufacturing date: 03/2018).
Event or Problem Description
It was reported through the results of a clinical trial that during an angioplasty procedure with a focused force percutaneous transluminal angioplasty (pta) balloon dilatation catheter, vessel dissection was identified after three inflations in the left superficial femoral artery.Reportedly, the dissection was treated with a drug eluting stent.The event was considered to be resolved.The subject was discharged one day after the index procedure.
Additional Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned, but medical records were provided.Based on the medical records, dissection following the use of a balloon can be confirmed, but determined to be unrelated to the device.Therefore the investigation is inconclusive, as the provided evidence does not confirm an alleged deficiency with the device.No medical records were provided with the updated information regarding occlusion.Therefore, the investigation is inconclusive for the reported occlusion, as there was no provided evidence to confirm an alleged deficiency with the device.Based upon the available information, the definitive root cause is unknown.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.(expiration date: 02/2020).
Event or Problem Description
It was reported through the results of a clinical trial that during an angioplasty procedure with a focused force percutaneous transluminal angioplasty (pta) balloon dilatation catheter, vessel dissection was identified after three inflations in the left superficial femoral artery.Reportedly, the dissection was treated with a drug eluting stent.The event was considered to be resolved.The subject was discharged one day after the index procedure.New information: it was reported that during 6-month follow up, stenosis was identified via imaging.

• Brand Name: ULTRASCORE FOCUSED FORCE PTA BALLOON
• Common Device Name: FOCUSED FORCE PTA BALLOON
• Manufacturer (Section D): BARD PERIPHERAL VASCULAR, INC.; 1625 w 3rd st.; tempe AZ 85281
• MDR Report Key: 8118464
• Report Number: 2020394-2018-02131
• Device Sequence Number: 211562
• Product Code: PNO
• UDI-Device Identifier: 00801741116865
• UDI-Public: (01)00801741116865
• Combination Product (Y/N): N
• Initial Reporter State: LA
• Initial Reporter Country: US
• PMA/510(K) Number: K172571
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: company representative,health
• Initial Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 11/05/2019

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Model Number: US3513068
• Device Catalogue Number: US3513068
• Device Lot Number: GFCN4105
• Was Device Available for Evaluation?: No
• Initial Date Received by Manufacturer: 11/05/2018
• Supplement Date Received by Manufacturer: 01/17/2019; 11/05/2019
• Initial Report FDA Received Date: 11/29/2018
• Supplement Report FDA Received Date: 02/11/2019; 11/05/2019
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: ASPIRIN, PRASUGREL; ASPIRIN, PRASUGREL; ASPIRIN, PRASUGREL; ASPIRIN, PRASUGREL
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 70 YR
• Patient Weight: 98